Get started
Author

Rolf Stahel

Observed names: Rolf STAHEL, Stahel, Rolf
OpenAlex ID: A5134903953
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
2015 · W.E.E. Eberhardt, D. De Ruysscher, et al. · Annals of Oncology · 401
PDF
Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non–Small Cell Lung Cancer
2026 · Mark A. Socinski, Rolf Stahel, et al. · JAMA Oncology · 7
Tprg-04 Etop 19-21 Usz-strike: Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
2026 · Michael Weller, Emilie Le Rhun, et al. · Neuro-Oncology Advances
PDF
GLOW-FDG: Generalized cancer LesiOn Whole-body segmentation model for $^{18}$F-FDG-PET/CT
2026 · Fritsak, Maksym, Rokuss, Maximilian, et al. · arXiv (Cornell University)
PDF
Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC
2026 · May-Lucie MEYER, Solange PETERS, et al. · Journal of Thoracic Oncology
PDF
Immunotherapy or targeted therapy with or without stereotactic radiosurgery for patients with brain metastases from melanoma or non-small cell lung cancer - The ETOP 19-21 USZ-STRIKE study
2025 · Weller, Michael; https://orcid.org/0000-0002-1748-174X, Le Rhun, Emilie; https://orcid.org/0000-0002-9408-3278, et al. · Zurich Open Repository and Archive (University of Zurich)
Randomised Intergroup Trial of First line Treatment for young Low-Risk Patients (< 61 years) with Diffuse Large B-Cell Non-Hodgkin's Lymphoma (DLBCL) with a CHOP-like Regimen with or without the Anti-CD20 Antibody Rituximab-6-Year Follow-up of the Mint Study of the Mabthera International Trial (MInT) Group
2010 · Pfreundschuh, Michael, Kuhnt, Evelyn, et al. · GRO
Works count: 8
Citation count: 408
H-index: 2
I10-index: 1
Year
Topic
Type